Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

21.81
-1.8800-7.94%
Volume:739.58K
Turnover:16.41M
Market Cap:1.42B
PE:-7.31
High:22.99
Open:22.82
Low:21.40
Close:23.69
Loading ...

BRIEF-Kymera Plans To Initiate A KT-621 Phase 1B Trial In Atopic Dermatitis Patients In 2Q25 With Data In 4Q25

Reuters
·
14 Jan

Kymera Therapeutics announces corporate goals for 2025

TIPRANKS
·
14 Jan

Kymera: Plans to Initiate a KT-621 Phase 1B Trial in Atopic Dermatitis Patients in 2Q25 With Data in 4Q25

THOMSON REUTERS
·
14 Jan

Kymera: Well-Capitalized With $850 Mln in Cash and Runway Into Mid-2027

THOMSON REUTERS
·
14 Jan

Kymera: to Initiate Parallel Phase 2B Trials in Ad and Asthma in Late 2025 and Early 2026, Respectively

THOMSON REUTERS
·
14 Jan

Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

GlobeNewswire
·
14 Jan

Kymera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14

GlobeNewswire
·
07 Jan

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Kymera Therapeutics (KYMR) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
02 Jan

Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal

TIPRANKS
·
27 Dec 2024

Kymera Therapeutics Initiated at Buy by BTIG

Dow Jones
·
11 Dec 2024

Kymera Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $60

THOMSON REUTERS
·
10 Dec 2024

BMO Capital Initiates Kymera Therapeutics at Market Perform With $55 Price Target

MT Newswires Live
·
06 Dec 2024

Kymera Therapeutics Initiated at Market Perform by BMO Capital

Dow Jones
·
06 Dec 2024

Kymera Therapeutics Shares Rise After Upgrade From Wells Fargo

MT Newswires Live
·
03 Dec 2024

Wells Fargo Upgrades Kymera Therapeutics to Overweight, Price Target is $57

MT Newswires Live
·
02 Dec 2024

Kymera Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
02 Dec 2024

Kymera Therapeutics to Participate in Upcoming December Investor Conferences

GlobeNewswire
·
26 Nov 2024

Kymera Therapeutics (KYMR) Gets a Hold from Wells Fargo

TIPRANKS
·
25 Nov 2024

U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix

Reuters
·
19 Nov 2024

Kymera Therapeutics Initiated at Overweight by Stephens & Co.

Dow Jones
·
18 Nov 2024